» Articles » PMID: 15067032

Transactivation of Sphingosine-1-phosphate Receptors by FcepsilonRI Triggering is Required for Normal Mast Cell Degranulation and Chemotaxis

Overview
Journal J Exp Med
Date 2004 Apr 7
PMID 15067032
Citations 158
Authors
Affiliations
Soon will be listed here.
Abstract

Mast cells secrete various substances that initiate and perpetuate allergic responses. Cross-linking of the high-affinity receptor for IgE (FcepsilonRI) in RBL-2H3 and bone marrow-derived mast cells activates sphingosine kinase (SphK), which leads to generation and secretion of the potent sphingolipid mediator, sphingosine-1-phosphate (S1P). In turn, S1P activates its receptors S1P1 and S1P2 that are present in mast cells. Moreover, inhibition of SphK blocks FcepsilonRI-mediated internalization of these receptors and markedly reduces degranulation and chemotaxis. Although transactivation of S1P1 and Gi signaling are important for cytoskeletal rearrangements and migration of mast cells toward antigen, they are dispensable for FcepsilonRI-triggered degranulation. However, S1P2, whose expression is up-regulated by FcepsilonRI cross-linking, was required for degranulation and inhibited migration toward antigen. Together, our results suggest that activation of SphKs and consequently S1PRs by FcepsilonRI triggering plays a crucial role in mast cell functions and might be involved in the movement of mast cells to sites of inflammation.

Citing Articles

Impact of Mast Cell Activation on Neurodegeneration: A Potential Role for Gut-Brain Axis and Infection.

Boziki M, Theotokis P, Kesidou E, Nella M, Bakirtzis C, Karafoulidou E Neurol Int. 2024; 16(6):1750-1778.

PMID: 39728753 PMC: 11677782. DOI: 10.3390/neurolint16060127.


Dysregulation of sphingolipid metabolism in pain.

Wang J, Zheng G, Wang L, Meng L, Ren J, Shang L Front Pharmacol. 2024; 15:1337150.

PMID: 38523645 PMC: 10957601. DOI: 10.3389/fphar.2024.1337150.


How do sphingosine-1-phosphate affect immune cells to resolve inflammation?.

Sun G, Wang B, Wu X, Cheng J, Ye J, Wang C Front Immunol. 2024; 15:1362459.

PMID: 38482014 PMC: 10932966. DOI: 10.3389/fimmu.2024.1362459.


New Therapeutic Options in Pulmonal Diseases: Sphingolipids and Modulation of Sphingolipid Metabolism.

Kleuser B, Schumacher F, Gulbins E Handb Exp Pharmacol. 2023; 284:289-312.

PMID: 37922034 DOI: 10.1007/164_2023_700.


Crosstalk of Mast Cells and Natural Killer Cells with Neurons in Chemotherapy-Induced Peripheral Neuropathy.

Yun H, Goel Y, Gupta K Int J Mol Sci. 2023; 24(16).

PMID: 37628724 PMC: 10454469. DOI: 10.3390/ijms241612543.


References
1.
Kluk M, Colmont C, Wu M, Hla T . Platelet-derived growth factor (PDGF)-induced chemotaxis does not require the G protein-coupled receptor S1P1 in murine embryonic fibroblasts and vascular smooth muscle cells. FEBS Lett. 2002; 533(1-3):25-8. DOI: 10.1016/s0014-5793(02)03742-0. View

2.
Idzko M, Panther E, Corinti S, Morelli A, Ferrari D, Herouy Y . Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. FASEB J. 2002; 16(6):625-7. DOI: 10.1096/fj.01-0625fje. View

3.
Sugimoto N, Takuwa N, Okamoto H, Sakurada S, Takuwa Y . Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform. Mol Cell Biol. 2003; 23(5):1534-45. PMC: 151702. DOI: 10.1128/MCB.23.5.1534-1545.2003. View

4.
Spiegel S, Milstien S . Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol. 2003; 4(5):397-407. DOI: 10.1038/nrm1103. View

5.
Gonzalez-Espinosa C, Odom S, Olivera A, Hobson J, Martinez M, Oliveira-Dos-Santos A . Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells. J Exp Med. 2003; 197(11):1453-65. PMC: 2193904. DOI: 10.1084/jem.20021806. View